Department of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität Munich, Butenandtstraße 7, 81377, Munich, Germany.
ChemMedChem. 2021 Oct 6;16(19):3094-3104. doi: 10.1002/cmdc.202100408. Epub 2021 Jul 28.
A straightforward screening of a compound library comprising 2439 substances for the identification of new inhibitors for the neurotransmitter transporters GlyT1 and GlyT2 is described. Screening and full-scale competition experiments were performed using recently developed GlyT1 and GlyT2 MS Binding Assays. That way for both targets, GlyT1 and GlyT2, ligands were identified, which exhibited affinities (pK values) in the low micromolar to sub-micromolar range. The majority of these binders exhibit new chemical scaffolds in the class of GlyT1 and GlyT2 inhibitors, which could be of interest for the development of new ligands with improved affinities for the target proteins. Additionally, compounds with excellent fluorescent properties were found for GlyT2, which renders them promising compounds for future fluorescence-based techniques. All in all, this study demonstrates that MS Binding Assays represent a powerful technology platform also well suited for the screening of compound libraries in a highly reliable and effective manner.
本文描述了一种直截了当的筛选方法,该方法使用包含 2439 种化合物的化合物库来鉴定神经递质转运蛋白 GlyT1 和 GlyT2 的新型抑制剂。筛选和全面竞争实验均使用最近开发的 GlyT1 和 GlyT2 MS 结合测定法进行。通过这种方法,针对这两个靶点 GlyT1 和 GlyT2,都鉴定出了亲和力(pK 值)处于低微摩尔到亚微摩尔范围内的配体。这些结合物中的大多数都属于 GlyT1 和 GlyT2 抑制剂类的新型化学支架,这可能对开发具有更高靶蛋白亲和力的新型配体具有重要意义。此外,还发现了对 GlyT2 具有优异荧光特性的化合物,这使得它们成为未来基于荧光的技术的有前途的化合物。总而言之,这项研究表明,MS 结合测定法是一种强大的技术平台,也非常适合以高度可靠和有效的方式筛选化合物库。